Cargando…

Use of Nanocarriers Containing Antitrypanosomal Drugs for the Treatment of Chagas Disease

Chagas disease, caused by the Trypanosoma cruzi parasitic protozoan, is a neglected tropical disease (NTD) of significant incidence in Latin America. Transmission to humans and other mammals is mainly via the vector insect from the Reduviidae family, popularly known as the kissing bug. There are oth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paiva, Diogo de Freitas, Matos, Ana Paula dos Santos, Garófalo, Denise de Abreu, do Nascimento, Tatielle, Monteiro, Mariana Sato de Souza de Bustamante, Santos-Oliveira, Ralph, Ricci-Junior, Eduardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459817/ https://www.ncbi.nlm.nih.gov/pubmed/37631078 http://dx.doi.org/10.3390/ph16081163

Ejemplares similares

Progression of Baseline Electrocardiogram Abnormalities in Chagas Patients Undergoing Antitrypanosomal Treatment
por: Soverow, Jonathan, et al.
Publicado: (2019)

Changes in workflow to a University Pharmacy to facilitate compounding and distribution of antiseptics for use against COVID-19
por: Nigro, Fiammetta, et al.
Publicado: (2021)

Nanotechnology Promoting the Development of Products from the Biodiversity of the Asteraceae Family
por: Yien, Raíssa Mara Kao, et al.
Publicado: (2023)

Histone deacetylases as targets for antitrypanosomal drugs
por: Zuma, Aline A, et al.
Publicado: (2018)

Antitrypanosomal Acetylene Fatty Acid Derivatives from the Seeds of Porcelia macrocarpa (Annonaceae)
por: Santos, Luciana de Á., et al.
Publicado: (2015)

Antitrypanosomal Activity of Novel Benzaldehyde-Thiosemicarbazone Derivatives from Kaurenoic Acid (†)
por: Haraguchi, Shirani K., et al.
Publicado: (2011)

In Vitro Antioxidant and Antitrypanosomal Activities of Extract and Fractions of Terminalia catappa
por: de Araújo, Sandra Alves, et al.
Publicado: (2023)

Antitrypanosomal butanolides from Aiouea trinervis
por: Nunes, Felipe Oliveira, et al.
Publicado: (2020)

Timing of Pharyngeal Swallow Events in Chagas’ Disease
por: dos Santos, Carla Manfredi, et al.
Publicado: (2014)

Advances in nanocarriers as drug delivery systems in Chagas disease
por: Quijia Quezada, Christian, et al.
Publicado: (2019)

Development and characterization of a nanoemulsion containing propranolol for topical delivery
por: Zanela da Silva Marques, Tatiana, et al.
Publicado: (2018)

Variability of Oral and Pharyngeal Transit Between Two Consecutive Swallows in Chagas’ Disease
por: Dantas, Roberto Oliveira, et al.
Publicado: (2013)

Risk of hospitalization and mortality due to COVID-19 in people with obesity: An analysis of data from a Brazilian state
por: dos Reis, Erika Cardoso, et al.
Publicado: (2022)

Enantiospecific antitrypanosomal in vitro activity of eflornithine
por: Boberg, Mikael, et al.
Publicado: (2021)

Antitrypanosomal Activity of 1,2,3-Triazole-Based Hybrids Evaluated Using In Vitro Preclinical Translational Models
por: Orlando, Lorraine Martins Rocha, et al.
Publicado: (2023)

Antitrypanosomal and Antileishmanial Activity of Chalcones and Flavanones from Polygonum salicifolium
por: Zheoat, Ahmed M., et al.
Publicado: (2021)

Evaluation of octyl p-methoxycinnamate included in liposomes and cyclodextrins in anti-solar preparations: preparations, characterizations and in vitro penetration studies
por: de Souza de Bustamante Monteiro, Mariana Sato, et al.
Publicado: (2012)

Asteraceae Plants as Sources of Compounds Against Leishmaniasis and Chagas Disease
por: Moraes Neto, Roberval Nascimento, et al.
Publicado: (2019)

Synthesis and Evaluation of Marine-Inspired Compounds Result in Hybrids with Antitrypanosomal and Antileishmanial Activities
por: Carvalho, Diogo Teixeira, et al.
Publicado: (2023)

GC-MS Characterization of Antibacterial, Antioxidant, and Antitrypanosomal Activity of Syzygium aromaticum Essential Oil and Eugenol
por: Teles, Amanda Mara, et al.
Publicado: (2021)

Structural and antitrypanosomal data of different carbasones of piperitone
por: Sakirigui, Amoussatou, et al.
Publicado: (2016)

Intramyocardial transplantation of cardiac mesenchymal stem cells reduces myocarditis in a model of chronic Chagas disease cardiomyopathy
por: Silva, Daniela Nascimento, et al.
Publicado: (2014)

Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain
por: Previti, Santo, et al.
Publicado: (2022)

Therapeutic effects of sphingosine kinase inhibitor N,N-dimethylsphingosine (DMS) in experimental chronic Chagas disease cardiomyopathy
por: Vasconcelos, Juliana Fraga, et al.
Publicado: (2017)

Discovery of 5-Phenylpyrazolopyrimidinone Analogs as Potent Antitrypanosomal Agents with In Vivo Efficacy
por: Zheng, Yang, et al.
Publicado: (2023)

Vimentin and Anti Vimentin Antibodies in Chagas' Disease
por: Nascimento, Marilda Savoia, et al.
Publicado: (2018)

Cell Therapy in Chagas Disease
por: Campos de Carvalho, Antonio C., et al.
Publicado: (2009)

Membranous nephropathy PLA2R+ associated with Chagas disease
por: Xavier-Júnior, José Cândido Caldeira, et al.
Publicado: (2015)

Aniba rosaeodora (Var. amazonica Ducke) Essential Oil: Chemical Composition, Antibacterial, Antioxidant and Antitrypanosomal Activity
por: Teles, Amanda Mara, et al.
Publicado: (2020)

Trypanosoma cruzi trans-Sialidase as a Potential Vaccine Target Against Chagas Disease
por: da Costa, Kelli Monteiro, et al.
Publicado: (2021)

Acute Chagas disease in the state of Pará, Amazon Region: is it increasing?
por: dos Santos, Valéria Regina Cavalcante, et al.
Publicado: (2018)

Antileishmanial and antitrypanosomal activity of the cutaneous secretion of Siphonops annulatus
por: Pinto, Erika Gracielle, et al.
Publicado: (2014)

Antitrypanosomal Alkaloids from the Marine Bacterium Bacillus pumilus
por: Martínez-Luis, Sergio, et al.
Publicado: (2012)

Chemical Derivatization and Characterization of Novel Antitrypanosomals for African Trypanosomiasis
por: Dofuor, Aboagye Kwarteng, et al.
Publicado: (2021)

Performance of Chimeric Trypanosoma cruzi Antigens in Serological Screening for Chagas Disease in Blood Banks
por: dos Santos, Emily Ferreira, et al.
Publicado: (2022)

Baroreflex Sensitivity and its Association with Arrhythmic Events in Chagas Disease
por: Santos, Astrid Meireles, et al.
Publicado: (2014)

Antileishmanial and antitrypanosomal activity of symmetrical dibenzyl-substituted α,β-unsaturated carbonyl-based compounds
por: Alkhaldi, Abdulsalam AM, et al.
Publicado: (2019)

From Benznidazole to New Drugs: Nanotechnology Contribution in Chagas Disease
por: Gomes, Daniele Cavalcante, et al.
Publicado: (2023)

Lipid Nanocarriers for Hyperproliferative Skin Diseases
por: Souto, Eliana B., et al.
Publicado: (2021)

Current situation and perspectives regarding human Chagas disease in midwestern of the state of Minas Gerais, Brazil
por: Matos, Christiane Santos, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_sc377cki4rfc4nhfeap7g52r9t